← The SEC Ephemeris: the whole map
Mesoblast, Inc. remestemcel-L manufactured at your Singapore location
In the graph: all 18 documents (1,209 pages).
- Ticker
- MESO, MEOBF
- Product
- remestemcel-L manufactured at your Singapore location
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- August 1, 2023
From FDA letters and SEC filings. Not investment or medical advice.